Anthem Biosciences Limited (ANTHEM) — Financial Results | 22 July 2026

· NSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Audio recording of earnings call made available
💡 Investor Takeaway
Shareholders can listen to the call to review financial discussion.

Anthem Biosciences Limited announced that the audio recording of its earnings call for the quarter ended June 30, 2026, held on July 22, 2026, is now available on its website at anthembio.com/wp-content/uploads/2026/07/IR-Call-Audio.mp3.

📄 View Original Announcement (PDF)

About Anthem Biosciences Limited (ANTHEM)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹53,084.93 Cr P/E: 91.9 ROE: 18.9% ROCE: 25.5% Div Yield: 0.21%

View full ANTHEM stock details →

📡 Get AI alerts when ANTHEM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track ANTHEM — Free

📊 More ANTHEM filings

See all ANTHEM filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when ANTHEM files new disclosures

Track ANTHEM filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track ANTHEM — Free

Free account · 2 AI queries/day